2017 RNA Editing Gordon Research Conference and Gordon Research Seminar
2017 RNA Editing Gordon Research Conference and Gordon Research Seminar
批准号:
9331005
负责人:
Reuben S Harris
金额:
$0.3万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-03-03 至 2018-02-28
关键词:
AddressAdvocateAreaAutoimmune DiseasesBioinformaticsBiological ProcessBiologyBrainCaliforniaChemicalsCollaborationsCommunicable DiseasesCytosineDNADNA Modification ProcessDeaminationDefectDiseaseEnzymesEventEvolutionFemaleFosteringGene Expression RegulationGenerationsGenetic CodeGrowthHealthHourHumanImmunityImmunologic Deficiency SyndromesInternationalLearningMalignant NeoplasmsMalignant lymphoid neoplasmMediatingMental disordersMentorsMetabolismMissionModificationMolecularMolecular MachinesMothersMutagenesisOralOrganismOxygenasesPostdoctoral FellowProcessRNARNA EditingRNA InterferenceRegulationResearchResearch PersonnelScienceScientistStudentsTechnologyTimeTrainingTransfer RNAUnderrepresented MinorityWomanadaptive immunityantiviral immunityapoB mRNA editing catalytic subunitcancer genomecareercareer developmentdesignepigenomicsinterdisciplinary collaborationlecturesmeetingsminority scientistmultidisciplinarynervous system disordernext generationnext generation sequencingnovelpeerpostersprogramssocialsymposiumtranscriptometumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
RNA and DNA undergo a wide variety of programmed chemical modifications in all organisms, and these
changes are essential for many biological processes including metabolism, gene regulation, brain function,
immunity, and evolution. Defects in these processes manifest as disease states including cancer, neurological
diseases, immunodeficiency syndromes, and infectious diseases. While different molecular machines are
responsible for generating the large and diverse repertoire of modifications in any given organism, the
researchers investigating these processes routinely encounter similar theoretical and technical challenges.
Thus, there is a strong need to foster a meeting among researchers at the forefront of this broad area in order
to overcome these hurdles and promote a deeper understanding of the underlying biology and resulting
disease processes. The biennial RNA Editing Gordon Research Conference (GRC) is the only international
meeting devoted to this mission. The 2017 meeting has three major aims. Aim 1 will be showcasing the latest
research on editing and modification mechanisms and technologies that impact human health. This aim will be
accomplished through 9 oral sessions with >60 talks including a keynote lecture by a Nobel Laureate, as well
as through 4 poster sessions with >75 poster presentations. The program is organized to maximize discussion,
learning, mentoring, and networking opportunities. Aim 2 will be creating opportunities for new and impactful
collaborations to develop between established investigators in editing and modification field and new
investigators and/or established investigators who are new to this area. This aim will be accomplished by
providing opportunities for formal and informal discussions. Formal discussions will follow all talks, and informal
discussions will occur during breaks, meals, open afternoons, poster sessions, and evening social periods. Aim
3 will be providing presentation, mentoring, and career development opportunities for all student, post-doctoral,
and under-represented trainees, who are destined to become the leaders of the next scientific generation. This
will be accomplished by holding a one and half day Gordon Research Seminar (GRS) for student and
postdoctoral trainees prior to the GRC. The GRS will have 12 oral presentations and >25 poster presentations,
as well as a career development keynote by a pioneer in the modification field. The GRS will provide a
dedicated forum for student and postdoctoral trainees to present and discuss research and network with peers
before participating in the GRC. This important event helps trainees to become relaxed and prepared to
engage and learn from senior mentors during the GRC. Additionally, the GRC will also feature an educational
opportunity called the Power Hour, which addresses the unique challenges faced by women in science. This
novel event will be hosted by a leader in the RNA Editing field and an advocate for women in science. Overall,
this biennial meeting is vital for the continued growth and advancement of the editing and modification fields,
the cross-pollination of other fields, and the training of the next generation of scientists.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Midwest AViDD Center
-
批准号:10631659
-
项目类别:
-
资助金额:$45.68万
-
财政年份:2022
-
负责人:Reuben S Harris
-
依托单位:
Midwest AViDD Center
-
批准号:10522804
-
项目类别:
-
资助金额:$6643.12万
-
财政年份:2022
-
负责人:Reuben S Harris
-
依托单位:
Administrative-Core-001
-
批准号:10707575
-
项目类别:
-
资助金额:$9.59万
-
财政年份:2022
-
负责人:Reuben S Harris
-
依托单位:
Project 3: Pandemic Virus Protease Inhibitors
-
批准号:10522812
-
项目类别:
-
资助金额:$288.0万
-
财政年份:2022
-
负责人:Reuben S Harris
-
依托单位:
Core A: Administration
-
批准号:10522805
-
项目类别:
-
资助金额:$750.56万
-
财政年份:2022
-
负责人:Reuben S Harris
-
依托单位:
PROJECT 1
-
批准号:10474975
-
项目类别:
-
资助金额:$27.51万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
APOBEC MUTAGENESIS IN BREAST CANCER
-
批准号:10474974
-
项目类别:
-
资助金额:$175.12万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
PROJECT 1
-
批准号:10916617
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
APOBEC MUTAGENESIS IN BREAST CANCER
-
批准号:10738334
-
项目类别:
-
资助金额:$8.05万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
PROJECT 1
-
批准号:9804091
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
APOBEC MUTAGENESIS IN BREAST CANCER
-
批准号:10225387
-
项目类别:
-
资助金额:$171.35万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
APOBEC MUTAGENESIS IN BREAST CANCER
-
批准号:10676574
-
项目类别:
-
资助金额:$9.59万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
APOBEC MUTAGENESIS IN BREAST CANCER
-
批准号:9804090
-
项目类别:
-
资助金额:$165.65万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
PROJECT 1
-
批准号:10225388
-
项目类别:
-
资助金额:$34.78万
-
财政年份:2019
-
负责人:Reuben S Harris
-
依托单位:
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
-
批准号:9127434
-
项目类别:
-
资助金额:$21.93万
-
财政年份:2016
-
负责人:Reuben S Harris
-
依托单位:
(PQ2) HIV INFECTION, APOBEC UPREGULATION, AND CANCER MUTAGENESIS
-
批准号:9271943
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2016
-
负责人:Reuben S Harris
-
依托单位:
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies
-
批准号:8233319
-
项目类别:
-
资助金额:$193.3万
-
财政年份:2011
-
负责人:Reuben S Harris
-
依托单位:
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies
-
批准号:8433365
-
项目类别:
-
资助金额:$199.77万
-
财政年份:2011
-
负责人:Reuben S Harris
-
依托单位:
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies
-
批准号:8689415
-
项目类别:
-
资助金额:$2.03万
-
财政年份:2011
-
负责人:Reuben S Harris
-
依托单位:
Critical Interactions of APOBEC3s: Molecular Approaches to Novel HIV Therapies
-
批准号:8536529
-
项目类别:
-
资助金额:$8.41万
-
财政年份:2011
-
负责人:Reuben S Harris
-
依托单位:
海外基金